Aytu Biopharma, Inc. (AYTU)
2.30
+0.02
(+0.88%)
USD |
NASDAQ |
Dec 12, 16:00
2.34
+0.04
(+1.74%)
After-Hours: 20:00
Aytu Biopharma Shareholders Equity (Quarterly): 23.17M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Omeros Corp. | -220.48M |
| GeoVax Labs, Inc. | 4.907M |
| Vistagen Therapeutics, Inc. | 66.34M |
| Precigen, Inc. | 41.87M |
| Daré Bioscience, Inc. | 2.858M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 124.99M |
| Total Liabilities (Quarterly) | 101.82M |
| Debt to Equity Ratio | 1.226 |
| Current Ratio | 1.229 |
| Net Debt Paydown Yield | -12.86% |